Aktis Oncology, Inc. (AKTS): Ownership & Insider Activity

Hedge funds and institutional managers reporting a position in AKTS. Based on the most recent 13F filing from each holder, sourced from SEC EDGAR.

Reported Holders
11
13F filers
Aggregate Value
$54.9M
Across holders
Last Price
$25.98
2026-08-24
Sector
GICS
Quarterly fund activity6 increased2 reduced1 exited
Full exits: SHAW D E & CO INC
Institutional Holders of AKTS
11 holders
ManagerTypeSharesMarket Value% of Total% of PortfolioActionQoQ ChangeQuarter
BAKER BROS. ADVISORS LP
CIK 0001263508
Hedge Fund996K$32.1M58.5%0.2%Unchanged+$0Q2 2026
ArrowMark Colorado Holdings LLC
CIK 0001483859
Hedge Fund246K$7.9M14.4%0.3%Reduced$-2.7MQ2 2026
Woodline Partners LP
CIK 0001784547
Hedge Fund100K$3.2M5.9%0.0%Unchanged+$0Q2 2026
SOROS FUND MANAGEMENT LLC
CIK 0001029160
Family Office100K$3.2M5.9%0.0%Unchanged+$0Q2 2026
RENAISSANCE TECHNOLOGIES LLC
CIK 0001037389
Hedge Fund95K$3.1M5.6%0.0%AddedQ2 2026
AQR CAPITAL MANAGEMENT LLC
CIK 0001167557
Hedge Fund48K$1.6M2.8%0.0%AddedQ2 2026
Squarepoint Ops LLC
CIK 0001642575
Hedge Fund38K$1.2M2.3%0.0%AddedQ2 2026
TWO SIGMA INVESTMENTS, LP
CIK 0001179392
Hedge Fund31K$996K1.8%0.0%AddedQ2 2026
CITADEL ADVISORS LLC
CIK 0001423053
Hedge Fund26K$823K1.5%0.0%Reduced$-1.6MQ2 2026
TUDOR INVESTMENT CORP ET AL
CIK 0000923093
Hedge Fund21K$690K1.3%0.0%AddedQ2 2026
110 of 11
1 / 2
Loading recent insider activity…